These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9518455)

  • 1. Recombinant production of cyanovirin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium.
    Mori T; Gustafson KR; Pannell LK; Shoemaker RH; Wu L; McMahon JB; Boyd MR
    Protein Expr Purif; 1998 Mar; 12(2):151-8. PubMed ID: 9518455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development.
    Colleluori DM; Tien D; Kang F; Pagliei T; Kuss R; McCormick T; Watson K; McFadden K; Chaiken I; Buckheit RW; Romano JW
    Protein Expr Purif; 2005 Feb; 39(2):229-36. PubMed ID: 15642474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein.
    Mori T; Shoemaker RH; Gulakowski RJ; Krepps BL; McMahon JB; Gustafson KR; Pannell LK; Boyd MR
    Biochem Biophys Res Commun; 1997 Sep; 238(1):218-22. PubMed ID: 9299482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of peptides that bind to cyanovirin-N, a potent human immunodeficiency virus-inactivating protein.
    Han Z; Simpson JT; Fivash MJ; Fisher R; Mori T
    Peptides; 2004 Apr; 25(4):551-61. PubMed ID: 15165709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a stable dimeric mutant of cyanovirin-N (CV-N) from a T7 phage-displayed CV-N mutant library.
    Han Z; Xiong C; Mori T; Boyd MR
    Biochem Biophys Res Commun; 2002 Apr; 292(4):1036-43. PubMed ID: 11944919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum.
    Gustafson KR; Sowder RC; Henderson LE; Cardellina JH; McMahon JB; Rajamani U; Pannell LK; Boyd MR
    Biochem Biophys Res Commun; 1997 Sep; 238(1):223-8. PubMed ID: 9299483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N).
    Gandhi MJ; Boyd MR; Yi L; Yang GG; Vyas GN
    Dev Biol (Basel); 2000; 102():141-8. PubMed ID: 10794101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins.
    Shenoy SR; O'Keefe BR; Bolmstedt AJ; Cartner LK; Boyd MR
    J Pharmacol Exp Ther; 2001 May; 297(2):704-10. PubMed ID: 11303061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV-inactivating protein, cyanovirin-N, does not block gp120-mediated virus-to-cell binding.
    Mariner JM; McMahon JB; O'Keefe BR; Nagashima K; Boyd MR
    Biochem Biophys Res Commun; 1998 Jul; 248(3):841-5. PubMed ID: 9704015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
    Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
    Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression, purification and activity determination of cyanovirin-N].
    Chen W; Han B; Qian C; Liu Q; Xiong S
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):538-44. PubMed ID: 20575444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.
    Boyd MR; Gustafson KR; McMahon JB; Shoemaker RH; O'Keefe BR; Mori T; Gulakowski RJ; Wu L; Rivera MI; Laurencot CM; Currens MJ; Cardellina JH; Buckheit RW; Nara PL; Pannell LK; Sowder RC; Henderson LE
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1521-30. PubMed ID: 9210678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic plant production of Cyanovirin-N, an HIV microbicide.
    Sexton A; Drake PM; Mahmood N; Harman SJ; Shattock RJ; Ma JK
    FASEB J; 2006 Feb; 20(2):356-8. PubMed ID: 16354721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refolding, purification, and characterization of human erythropoietin binding protein produced in Escherichia coli.
    Johnson DL; Middleton SA; McMahon F; Barbone FP; Kroon D; Tsao E; Lee WH; Mulcahy LS; Jolliffe LK
    Protein Expr Purif; 1996 Feb; 7(1):104-13. PubMed ID: 9172774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino-terminal charge affects the periplasmic accumulation of recombinant heregulin/EGF hybrids exported using the Escherichia coli alkaline phosphatase signal sequence.
    Campion SR; Elsasser E; Chung R
    Protein Expr Purif; 1997 Aug; 10(3):331-9. PubMed ID: 9268680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial expression and characterization of chicken apolipoprotein A-I.
    Kiss RS; Kay CM; Ryan RO
    Protein Expr Purif; 1998 Apr; 12(3):353-60. PubMed ID: 9535703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domain-swapped structure of a mutant of cyanovirin-N.
    Botos I; Mori T; Cartner LK; Boyd MR; Wlodawer A
    Biochem Biophys Res Commun; 2002 May; 294(1):184-90. PubMed ID: 12054761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant technology as an alternative to chemical peptide synthesis: expression and characterization of HIV-1 Rev recombinant peptides.
    Lepage P; Heckel C; Humbert S; Stahl S; Rautmann G
    Anal Biochem; 1993 Aug; 213(1):40-8. PubMed ID: 8238880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a mutant recombinant S100 protein using electrospray ionization mass spectrometry.
    Raftery MJ; Harrison CA; Geczy CL
    Rapid Commun Mass Spectrom; 1997; 11(4):405-9. PubMed ID: 9069643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of anti-HIV peptides from Dorstenia contrajerva and Treculia obovoidea.
    Bokesch HR; Charan RD; Meragelman KM; Beutler JA; Gardella R; O'Keefe BR; McKee TC; McMahon JB
    FEBS Lett; 2004 Jun; 567(2-3):287-90. PubMed ID: 15178338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.